Sigma-Aldrich Q2 Sales Rise 3 Percent | GenomeWeb

NEW YORK (GenomeWeb) – NEW YORK (GenomeWeb) – Sigma-Aldrich today reported a 3 percent increase in sales in the second quarter as revenues rose to $701 million from $681 million in the year-ago period.

Analysts on average had expected the firm to report $705.9 million for the quarter, which ended on June 30.

Sales in Sigma-Aldrich's Research business ticked up 1 percent year over year to $357 million from $353 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.